DCTH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Delcath Systems Inc (DCTH) is not a strong buy at the moment for a beginner, long-term investor. While the company shows potential for growth in the long term with its HEPZATO expansion and increasing revenue, the current technical indicators, lack of positive trading signals, and weak financial performance trends suggest that the stock is better suited for monitoring rather than immediate investment.
The technical indicators are bearish. The MACD is negatively expanding, RSI is neutral at 43.083, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point of 9.4, with key support at 8.987 and resistance at 9.813.
The company has issued guidance for at least $100M in sales for FY26, indicating potential long-term growth. Analysts maintain a Buy rating, citing HEPZATO as a steady contributor and a driver for future growth.
The company's Q4 2025 financials show declining net income (-44.20% YoY), EPS (-54.55% YoY), and gross margin (-0.51% YoY). The stock has bearish technical indicators, and there are no recent news or significant trading trends from hedge funds, insiders, or Congress.
In Q4 2025, revenue increased by 37.27% YoY to $20.73M, but net income dropped to -$1.896M. EPS fell to -$0.05, and gross margin slightly decreased to 85.48%.
Analysts maintain a Buy rating but have lowered the price target from $29 to $27 due to increased expenses for HEPZATO expansion. They view the expense increase as a long-term growth driver despite short-term weakness.
